Product Images Sildenafil
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 9 images provide visual information about the product associated with Sildenafil NDC 50436-5517 by Unit Dose Services, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 6: Kaplan-Meier Plot of Mortality by Sildenafil Dose - image 01
sildenafil citrate structural formula - image 02
Figure 9. Change From Baseline in 6 Minute Walk Distance (Meters) at Weeks 4, 8, and 12 in Study 1: Mean (95% Confidence Interval) - image 05
Figure 10. Placebo-Corrected Change From Baseline in 6 Minute Walk Distance (Meters) at Week 12 by Study Subpopulation in Study 1: Mean (95% Confidence Interval) - image 06
The document presents a table with data related to the efficacy of Sildenafil in treating Pulmonary Arterial Hypertension. The table includes patient gender, age, disease classification, etiology, and functional capacity. It also displays the mean pulmonary arterial pressure, placebo-corrected change in 6-minute walk distance, and PVRI.*
Figure 11. Kaplan-Meier Plot of Time (in Days) to Clinical Worsening of PAH in Study 2 - image 07
Figure 12. Mean Change from Baseline in Six Minute Walk (meters) by Visit to Week 12 – ITT Population Sildenafil Protocol A1481244 - image 08
This appears to be a chart or graph related to a study on the effects of different doses of sildenafil (a medication used for erectile dysfunction) on participants over a period of 12 weeks. The x-axis shows the weeks of the study, while the y-axis indicates the change from baseline in meters. The plot shows the mean change from baseline for each treatment (represented by different colored lines) at each visit up to week 12. The chart appears to compare the effects of different doses of sildenafil (10 mg and 20 mg taken three times a day) with a placebo.*
Label Image - lbl504365517
This is a description of a medication called Sildenafil with a strength of 20mg. The NDC number is 50436.5517-1, and it appears to come in a unit dose form. However, due to the incomplete and fragmented nature of the text, it is possible that there is missing or erroneous information, and some parts of the text are not legible or understandable.*
\\Client\X$\Products\Sildenafil Tabs USP, 20 mg (078380)\Submissions\2016-11-03 (Piramal) - AJK\Working\Inserts\Image files\sildenafil-f7new.jpg - sildenafil f7new
This is a drug interaction table that lists the drugs Atorvastatin, Azithromycin, Bosentan, Cimetidine, Erythromycin, Maalox, Oral Contraceptives, Ritonavir and Saquinavirt. The table shows the fold change and 90% Confidence Interval (CI) recommendation indicating whether dose adjustment is needed or not for these drugs when taken with Sildenafil. It also includes a note stating that co-administration with bosentan therapy is not recommended and that there is no benefit on exercise capacity.*
\\Client\X$\Products\Sildenafil Tabs USP, 20 mg (078380)\Submissions\2016-11-03 (Piramal) - AJK\Working\Inserts\Image files\sildenafil-f8new.jpg - sildenafil f8new
This is a list of drugs that interact with Acenocoumarol, specifying their fold change and 90% CI recommendations for INR AUC and Cmax with either dose adjustment or no dose adjustment, or if it is not recommended. The table also includes a chart showing the change relative to the interacting drug alone with a solid line at x=1, and some notes on Doxazosin1, Doxazosin2, Doxazosin3, Ritonavir and Bosentan.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.